Truist raised the firm’s price target on American Healthcare REIT (AHR) to $44 from $38 and keeps a Buy rating on the shares after its “strong” results and raised guidance. The company appears extremely well positioned in terms of alignment with industry trends and due to company specific characteristics/strategy, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $45 from $39 at RBC Capital
- American Healthcare REIT Reports Strong Earnings Call
- American Healthcare REIT price target raised to $45 from $40 at Citizens JMP
- American Healthcare REIT Faces Risks from New Tax Legislation and Medicaid Cuts
- American Healthcare REIT Reports Strong Q2 2025 Results